Extended interval BNT162b2 vaccination enhances peak antibody generation

The BNT162b2 vaccine is highly effective against COVID-19 infection and was delivered with a 3-week time interval in registration studies(1). However, many countries extended this interval to accelerate population coverage with a single vaccine. It is not known how immune responses are influenced by...

Descripción completa

Detalles Bibliográficos
Autores principales: Parry, Helen, Bruton, Rachel, Stephens, Christine, Bentley, Christopher, Brown, Kevin, Amirthalingam, Gayatri, Hallis, Bassam, Otter, Ashley, Zuo, Jianmin, Moss, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795435/
https://www.ncbi.nlm.nih.gov/pubmed/35087066
http://dx.doi.org/10.1038/s41541-022-00432-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795435/
https://www.ncbi.nlm.nih.gov/pubmed/35087066
http://dx.doi.org/10.1038/s41541-022-00432-w

Ejemplares similares